Pharmaceutical pricing and research and development investment: A secondary analysis that investigates product and patent output

by Gladin, Chris, Ph.D., CAPELLA UNIVERSITY, 2006, 88 pages; 3238563


The purpose of this study is to examine the various types of international drug price regulation and how that regulation impacts R&D expenditure in specific countries. Conversely, do R&D expenditures ultimately dictate pricing levels within select countries; that is, does a country that has lower R&D investment equate to lower drug prices. This study used a descriptive design that focused on the present condition. The descriptive method includes empirical observation through the use of secondary data analysis on the current conditions. This method was utilized to determine the functional relationship and significant effect of pharmaceutical pricing regulation to R&D investment resulting in decreased product and patent output.

AdviserJohn Machnic
Source TypeDissertation
SubjectsManagement; Pharmaceutical sciences; Health care management
Publication Number3238563

About ProQuest Dissertations & Theses
With nearly 4 million records, the ProQuest Dissertations & Theses (PQDT) Global database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

PQDT Global combines content from a range of the world's premier universities - from the Ivy League to the Russell Group. Of the nearly 4 million graduate works included in the database, ProQuest offers more than 2.5 million in full text formats. Of those, over 1.7 million are available in PDF format. More than 90,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - - or contact ProQuest Support.